Copyright Reports & Markets. All rights reserved.

Global Cancer Therapies Market Size, Status and Forecast 2019-2025

Request for Sample of this report
Buy now

1 Report Overview

  • 1.1 Study Scope
  • 1.2 Key Market Segments
  • 1.3 Players Covered: Ranking by Cancer Therapies Revenue
  • 1.4 Market by Type
    • 1.4.1 Global Cancer Therapies Market Size Growth Rate by Type: 2020 VS 2026
    • 1.4.2 Immunological and Vaccine Approaches
    • 1.4.3 Antiproliferative Approaches
    • 1.4.4 Photodynamic Therapy
    • 1.4.5 Gene Therapy Approaches
    • 1.4.6 Cell Cycle and Apoptosis Approaches
  • 1.5 Market by Application
    • 1.5.1 Global Cancer Therapies Market Share by Application: 2020 VS 2026
    • 1.5.2 Hospital Use
    • 1.5.3 Clinic Use
    • 1.5.4 Household
    • 1.5.5 Other
  • 1.6 Study Objectives
  • 1.7 Years Considered

2 Global Growth Trends

  • 2.1 Global Cancer Therapies Market Perspective (2015-2026)
  • 2.2 Global Cancer Therapies Growth Trends by Regions
    • 2.2.1 Cancer Therapies Market Size by Regions: 2015 VS 2020 VS 2026
    • 2.2.2 Cancer Therapies Historic Market Share by Regions (2015-2020)
    • 2.2.3 Cancer Therapies Forecasted Market Size by Regions (2021-2026)
  • 2.3 Industry Trends and Growth Strategy
    • 2.3.1 Market Top Trends
    • 2.3.2 Market Drivers
    • 2.3.3 Market Challenges
    • 2.3.4 Porter’s Five Forces Analysis
    • 2.3.5 Cancer Therapies Market Growth Strategy
    • 2.3.6 Primary Interviews with Key Cancer Therapies Players (Opinion Leaders)

3 Competition Landscape by Key Players

  • 3.1 Global Top Cancer Therapies Players by Market Size
    • 3.1.1 Global Top Cancer Therapies Players by Revenue (2015-2020)
    • 3.1.2 Global Cancer Therapies Revenue Market Share by Players (2015-2020)
    • 3.1.3 Global Cancer Therapies Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 3.2 Global Cancer Therapies Market Concentration Ratio
    • 3.2.1 Global Cancer Therapies Market Concentration Ratio (CR5 and HHI)
    • 3.2.2 Global Top 10 and Top 5 Companies by Cancer Therapies Revenue in 2019
  • 3.3 Cancer Therapies Key Players Head office and Area Served
  • 3.4 Key Players Cancer Therapies Product Solution and Service
  • 3.5 Date of Enter into Cancer Therapies Market
  • 3.6 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)

  • 4.1 Global Cancer Therapies Historic Market Size by Type (2015-2020)
  • 4.2 Global Cancer Therapies Forecasted Market Size by Type (2021-2026)

5 Market Size by Application (2015-2026)

  • 5.1 Global Cancer Therapies Market Size by Application (2015-2020)
  • 5.2 Global Cancer Therapies Forecasted Market Size by Application (2021-2026)

6 North America

  • 6.1 North America Cancer Therapies Market Size (2015-2020)
  • 6.2 Cancer Therapies Key Players in North America (2019-2020)
  • 6.3 North America Cancer Therapies Market Size by Type (2015-2020)
  • 6.4 North America Cancer Therapies Market Size by Application (2015-2020)

7 Europe

  • 7.1 Europe Cancer Therapies Market Size (2015-2020)
  • 7.2 Cancer Therapies Key Players in Europe (2019-2020)
  • 7.3 Europe Cancer Therapies Market Size by Type (2015-2020)
  • 7.4 Europe Cancer Therapies Market Size by Application (2015-2020)

8 China

  • 8.1 China Cancer Therapies Market Size (2015-2020)
  • 8.2 Cancer Therapies Key Players in China (2019-2020)
  • 8.3 China Cancer Therapies Market Size by Type (2015-2020)
  • 8.4 China Cancer Therapies Market Size by Application (2015-2020)

9 Japan

  • 9.1 Japan Cancer Therapies Market Size (2015-2020)
  • 9.2 Cancer Therapies Key Players in Japan (2019-2020)
  • 9.3 Japan Cancer Therapies Market Size by Type (2015-2020)
  • 9.4 Japan Cancer Therapies Market Size by Application (2015-2020)

10 Southeast Asia

  • 10.1 Southeast Asia Cancer Therapies Market Size (2015-2020)
  • 10.2 Cancer Therapies Key Players in Southeast Asia (2019-2020)
  • 10.3 Southeast Asia Cancer Therapies Market Size by Type (2015-2020)
  • 10.4 Southeast Asia Cancer Therapies Market Size by Application (2015-2020)

11 India

  • 11.1 India Cancer Therapies Market Size (2015-2020)
  • 11.2 Cancer Therapies Key Players in India (2019-2020)
  • 11.3 India Cancer Therapies Market Size by Type (2015-2020)
  • 11.4 India Cancer Therapies Market Size by Application (2015-2020)

12 Central & South America

  • 12.1 Central & South America Cancer Therapies Market Size (2015-2020)
  • 12.2 Cancer Therapies Key Players in Central & South America (2019-2020)
  • 12.3 Central & South America Cancer Therapies Market Size by Type (2015-2020)
  • 12.4 Central & South America Cancer Therapies Market Size by Application (2015-2020)

13 Key Players Profiles

  • 13.1 Amgen
    • 13.1.1 Amgen Company Details
    • 13.1.2 Amgen Business Overview
    • 13.1.3 Amgen Cancer Therapies Introduction
    • 13.1.4 Amgen Revenue in Cancer Therapies Business (2015-2020))
    • 13.1.5 Amgen Recent Development
  • 13.2 AstraZeneca
    • 13.2.1 AstraZeneca Company Details
    • 13.2.2 AstraZeneca Business Overview
    • 13.2.3 AstraZeneca Cancer Therapies Introduction
    • 13.2.4 AstraZeneca Revenue in Cancer Therapies Business (2015-2020)
    • 13.2.5 AstraZeneca Recent Development
  • 13.3 Bristol-Myers Squibb
    • 13.3.1 Bristol-Myers Squibb Company Details
    • 13.3.2 Bristol-Myers Squibb Business Overview
    • 13.3.3 Bristol-Myers Squibb Cancer Therapies Introduction
    • 13.3.4 Bristol-Myers Squibb Revenue in Cancer Therapies Business (2015-2020)
    • 13.3.5 Bristol-Myers Squibb Recent Development
  • 13.4 Bayer AG
    • 13.4.1 Bayer AG Company Details
    • 13.4.2 Bayer AG Business Overview
    • 13.4.3 Bayer AG Cancer Therapies Introduction
    • 13.4.4 Bayer AG Revenue in Cancer Therapies Business (2015-2020)
    • 13.4.5 Bayer AG Recent Development
  • 13.5 F. Hoffmann-La Roche Ltd
    • 13.5.1 F. Hoffmann-La Roche Ltd Company Details
    • 13.5.2 F. Hoffmann-La Roche Ltd Business Overview
    • 13.5.3 F. Hoffmann-La Roche Ltd Cancer Therapies Introduction
    • 13.5.4 F. Hoffmann-La Roche Ltd Revenue in Cancer Therapies Business (2015-2020)
    • 13.5.5 F. Hoffmann-La Roche Ltd Recent Development
  • 13.6 GlaxoSmithKline PLC
    • 13.6.1 GlaxoSmithKline PLC Company Details
    • 13.6.2 GlaxoSmithKline PLC Business Overview
    • 13.6.3 GlaxoSmithKline PLC Cancer Therapies Introduction
    • 13.6.4 GlaxoSmithKline PLC Revenue in Cancer Therapies Business (2015-2020)
    • 13.6.5 GlaxoSmithKline PLC Recent Development
  • 13.7 Johnson & Johnson
    • 13.7.1 Johnson & Johnson Company Details
    • 13.7.2 Johnson & Johnson Business Overview
    • 13.7.3 Johnson & Johnson Cancer Therapies Introduction
    • 13.7.4 Johnson & Johnson Revenue in Cancer Therapies Business (2015-2020)
    • 13.7.5 Johnson & Johnson Recent Development
  • 13.8 Merck & Co. Inc.
    • 13.8.1 Merck & Co. Inc. Company Details
    • 13.8.2 Merck & Co. Inc. Business Overview
    • 13.8.3 Merck & Co. Inc. Cancer Therapies Introduction
    • 13.8.4 Merck & Co. Inc. Revenue in Cancer Therapies Business (2015-2020)
    • 13.8.5 Merck & Co. Inc. Recent Development
  • 13.9 Novartis AG
    • 13.9.1 Novartis AG Company Details
    • 13.9.2 Novartis AG Business Overview
    • 13.9.3 Novartis AG Cancer Therapies Introduction
    • 13.9.4 Novartis AG Revenue in Cancer Therapies Business (2015-2020)
    • 13.9.5 Novartis AG Recent Development
  • 13.10 Pfizer Inc.
    • 13.10.1 Pfizer Inc. Company Details
    • 13.10.2 Pfizer Inc. Business Overview
    • 13.10.3 Pfizer Inc. Cancer Therapies Introduction
    • 13.10.4 Pfizer Inc. Revenue in Cancer Therapies Business (2015-2020)
    • 13.10.5 Pfizer Inc. Recent Development

14 Analyst's Viewpoints/Conclusions

    15 Appendix

    • 15.1 Research Methodology
      • 15.1.1 Methodology/Research Approach
      • 15.1.2 Data Source
    • 15.2 Disclaimer

    Cancer Therapies market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Cancer Therapies market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.

    The key players covered in this study
    Amgen
    AstraZeneca
    Bristol-Myers Squibb
    Bayer AG
    F. Hoffmann-La Roche Ltd
    GlaxoSmithKline PLC
    Johnson & Johnson
    Merck & Co. Inc.
    Novartis AG
    Pfizer Inc.

    Market segment by Type, the product can be split into
    Immunological and Vaccine Approaches
    Antiproliferative Approaches
    Photodynamic Therapy
    Gene Therapy Approaches
    Cell Cycle and Apoptosis Approaches
    Market segment by Application, split into
    Hospital Use
    Clinic Use
    Household
    Other

    Market segment by Regions/Countries, this report covers
    North America
    Europe
    China
    Japan
    Southeast Asia
    India
    Central & South America

    Buy now